These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10904880)

  • 1. PCNA immunostaining as a valid alternative to tritiated thymidine-autoradiography to detect proliferative cell fraction in transitional cell bladder carcinomas.
    Lavezzi AM; Terni L; Matturri L
    In Vivo; 2000; 14(3):447-51. PubMed ID: 10904880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.
    Serio G
    Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of p53 and proliferating cell nuclear antigen (PCNA) in bladder cancer: positive immunostaining and radiosensitivity.
    Ogura K; Habuchi T; Yamada H; Ogawa O; Yoshida O
    Int J Urol; 1995 Nov; 2(5):302-8. PubMed ID: 8749948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of different biomarkers (DNA, PCNA, apoptosis and karyotype) in prognostic evaluation of superficial transitional cell bladder carcinoma.
    Lavezzi AM; Biondo B; Cazzullo A; Giordano F; Pallotti F; Turconi P; Matturri L
    Anticancer Res; 2001; 21(2B):1279-84. PubMed ID: 11396199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder.
    Waldman FM; Carroll PR; Cohen MB; Kerschmann R; Chew K; Mayall BH
    Mod Pathol; 1993 Jan; 6(1):20-4. PubMed ID: 8093979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
    Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
    Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues.
    Galand P; Degraef C
    Cell Tissue Kinet; 1989 Sep; 22(5):383-92. PubMed ID: 2575456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Growth fractions of bladder cancer determined by proliferating cell nuclear antigen immunostaining].
    Kuroda H; Yasunaga Y; Takatera H; Fujioka H; Ohnishi A; Tsujimoto M
    Hinyokika Kiyo; 1994 May; 40(5):379-82. PubMed ID: 7912881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Apoptosis and expression of PCNA in superficial transitional cell bladder cancer as related to recurrence].
    Chen L; Wang X; Mei H; Chen W
    Zhonghua Wai Ke Za Zhi; 1998 Aug; 36(8):484-6. PubMed ID: 11825447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of proliferating cell nuclear antigen (PCNA) in breast cancer using anti-PCNA PC10 and 19A2: correlation with 5-bromo-2'-deoxyuridine or tritiated thymidine labeling and flow cytometric analysis.
    He W; Meyer JS; Scrivner DL; Koehm S; Hughes J
    Biotech Histochem; 1994 Jul; 69(4):203-12. PubMed ID: 7918835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mapping of histology and cell proliferation in human bladder cancer: an immunohistochemical study.
    Igawa M; Urakami S; Shirakawa H; Shiina H; Ishibe T; Usui T; Moriyama H
    Hiroshima J Med Sci; 1995 Dec; 44(4):93-7. PubMed ID: 8857231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
    Cheville JC; Terrell RB; Cohen MB
    Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node revealing solution: a rapid method for the fixation of cystectomy specimens.
    Koren R; Paz A; Konichezsky M; Sadikov E; Klein B; Livne P; Gal R
    Pathol Res Pract; 1999; 195(2):77-80. PubMed ID: 10093825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas.
    Krüger S; Müller H
    Br J Urol; 1995 Apr; 75(4):480-4. PubMed ID: 7788260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of proliferating cell nuclear antigen in paraffin-embedded specimens is dependent on preembedding tissue handling and fixation.
    Burford-Mason AP; MacKay AJ; Cummins M; Dardick I
    Arch Pathol Lab Med; 1994 Oct; 118(10):1007-13. PubMed ID: 7524464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
    Ghazvini S; Kroll S; Char DH; Frigillana H
    Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of proliferating cell nuclear antigen in superficial bladder cancer--application to paraffin-embedded tissue sections].
    Wada T; Shimabukuro T; Kurisu H; Shameem IA; Yoshihiro S; Matsuyama H; Naito K; Hashimoto O; Tanaka K
    Hinyokika Kiyo; 1993 Apr; 39(4):313-9. PubMed ID: 8099249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new cell proliferating marker: cytosolic thymidine kinase as compared to proliferating cell nuclear antigen in patients with colorectal carcinoma.
    Wu J; Mao Y; He L; Wang N; Wu C; He Q; Skog S
    Anticancer Res; 2000; 20(6C):4815-20. PubMed ID: 11205225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of the proliferation status (PCNA) and p53 immunohistochemistry as a prognostic factor for the clinical course of superficial cancer of the urinary bladder].
    Kuczyk MA; Serth J; Bokemeyer C; Hervatin C; Oelke M; Oelert F; Höfner K; Jonas U
    Urologe A; 1995 Mar; 34(2):146-52. PubMed ID: 7754587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of human bladder tumor histoculture proliferation and sensitivity to mitomycin C with tumor pathobiology.
    Schmittgen TD; Weaver JM; Badalament RA; Wientjes MG; Klein EA; Young DC; Au JL
    J Urol; 1994 Nov; 152(5 Pt 1):1632-6. PubMed ID: 7933219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.